Araştırma Makalesi

Exploring the Prognostic Role of SLC9A1 (NHE1) in Colon Adenocarcinoma

Cilt: 36 Sayı: 2026 31 Mart 2026
PDF İndir
EN TR

Exploring the Prognostic Role of SLC9A1 (NHE1) in Colon Adenocarcinoma

Öz

Aim: The solute carrier family 9 member A(SLC9A1), encoding the Na⁺/H⁺ exchanger isoform 1(NHE1), plays a key role in regulating intracellular pH and has been implicated in cancer progression. However, its prognostic and biological relevance in colon adenocarcinoma remains insufficiently explored.
Methods: Using transcriptomic and clinical data from The Cancer Genome Atlas(TCGA-COAD), we investigated the association between SLC9A1 expression and molecular alterations in colon cancer. Patients were stratified into high and low SLC9A1 expression groups. Differential gene expression analysis was performed using DESeq2. Gene set enrichment analysis with Hallmark gene sets and pathway enrichment via Gene Ontology and Kyoto Encyclopedia of Genes and Genomes(KEGG) databases were applied. Kaplan-Meier survival analysis and log-rank tests assessed prognostic value. Additionally, expression levels were compared across microsatellite instability(MSI) subtypes.
Results: Differential Expression Analysis identified 12,789 differentially expressed genes(11,991 upregulated and 798 downregulated) in SLC9A1-high tumors. Although Hallmark GSEA did not yield statistically significant enrichment under adjusted p-value thresholds, pathway-level analysis highlighted biological themes such as ribosome biogenesis and suppression of epithelialmesenchymal transition. Enrichment was also noted in Wnt/β-catenin, Notch, and Transforming Growth Factor Beta(TGF-β) signaling pathways. Survival analysis showed a non-significant trend toward reduced overall survival in the SLC9A1-high group. No significant expression differences were found between microsatellite instability-high(MSI-H) and microsatellite-stable(MSS) tumors.
Conclusions: While SLC9A1 expression is not an independent prognostic biomarker in colon adenocarcinoma, it may contribute to tumor progression through regulation of key pathways linked to pH balance and cellular adaptation. Further validation in functional models is warranted to elucidate its mechanistic role and therapeutic potential.

Anahtar Kelimeler

Colon Adenocarcinoma, SLC9A1, Biophysics, Bioinformatics

Etik Beyan

This study used publicly available, de-identified data from The Cancer Genome Atlas (TCGA) database. Therefore, institutional review board (IRB) approval and informed consent were not required

Teşekkür

The results presented in this study are in whole or part based upon data generated by The Cancer Genome Atlas (TCGA) Research Network (https://www.cancer.gov/tcga). The authors would like to thank the contributors of the TCGA-COAD project for making their data publicly available, enabling further research into the molecular mechanisms of colon cancer. We also acknowledge the developers and maintainers of the open-source R packages used in this analysis for their valuable contributions to the scientific community.

Kaynakça

  1. 1. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229–63.
  2. 2. Yan L, Shi J, Zhu J. Cellular and molecular events in colorectal cancer: biological mechanisms, cell death pathways, drug resistance and signalling network interactions. Discover Oncology 2024 15:1. 2024;15(1):1–29.
  3. 3. Zhou X, Jiang M, Liu Z, Xu M, Chen N, Wu Z, et al. Na+/H+-Exchanger Family as Novel Prognostic Biomarkers in Colorectal Cancer. J Oncol. 2021;2021:3241351.
  4. 4. Parks SK, Cormerais Y, Durivault J, Pouyssegur J. Genetic disruption of the pHi-regulating proteins Na+/H+ exchanger 1 (SLC9A1) and carbonic anhydrase 9 severely reduces growth of colon cancer cells. Oncotarget. 2016;8(6):10225.
  5. 5. Xu H, Ghishan FK, Kiela PR. SLC9 Gene Family: Function, Expression, and Regulation. Compr Physiol. 2018;8(2):555.
  6. 6. Zhang Z, Liu S, Xu T, Chen N, Liu C, Yang H, et al. Tumor suppressor SLC9A2 inhibits colorectal cancer metastasis and reverses immunotherapy resistance by suppressing angiogenesis. J Exp Clin Cancer Res. 2025;44(1):172.
  7. 7. Wu D, Xu Z, Wang J. SLC9A1 Binding mTOR Signaling Pathway-Derived Risk Score Predicting Survival and Immune in Clear Cell Renal Cell Carcinoma. J Oncol. 2023;2023(1):3937352.
  8. 8. Colaprico A, Silva TC, Olsen C, Garofano L, Cava C, Garolini D, et al. TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 2016;44(8):e71–e71.
  9. 9. Therneau TM. Survival Analysis [R package survival version 3.8-3]. CRAN: Contributed Packages. 2024 Dec 17;Available from: https://CRAN.R-project.org/package=survival
  10. 10. Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):1–21.

Kaynak Göster

APA
Adalı, Y., Ozdil, B., & Koseler, A. (2026). Exploring the Prognostic Role of SLC9A1 (NHE1) in Colon Adenocarcinoma. Genel Tıp Dergisi, 36(2026), 1-8. https://doi.org/10.54005/geneltip.1758107
AMA
1.Adalı Y, Ozdil B, Koseler A. Exploring the Prognostic Role of SLC9A1 (NHE1) in Colon Adenocarcinoma. Genel Tıp Derg. 2026;36(2026):1-8. doi:10.54005/geneltip.1758107
Chicago
Adalı, Yasemin, Berrin Ozdil, ve Aylin Koseler. 2026. “Exploring the Prognostic Role of SLC9A1 (NHE1) in Colon Adenocarcinoma”. Genel Tıp Dergisi 36 (2026): 1-8. https://doi.org/10.54005/geneltip.1758107.
EndNote
Adalı Y, Ozdil B, Koseler A (01 Mart 2026) Exploring the Prognostic Role of SLC9A1 (NHE1) in Colon Adenocarcinoma. Genel Tıp Dergisi 36 2026 1–8.
IEEE
[1]Y. Adalı, B. Ozdil, ve A. Koseler, “Exploring the Prognostic Role of SLC9A1 (NHE1) in Colon Adenocarcinoma”, Genel Tıp Derg, c. 36, sy 2026, ss. 1–8, Mar. 2026, doi: 10.54005/geneltip.1758107.
ISNAD
Adalı, Yasemin - Ozdil, Berrin - Koseler, Aylin. “Exploring the Prognostic Role of SLC9A1 (NHE1) in Colon Adenocarcinoma”. Genel Tıp Dergisi 36/2026 (01 Mart 2026): 1-8. https://doi.org/10.54005/geneltip.1758107.
JAMA
1.Adalı Y, Ozdil B, Koseler A. Exploring the Prognostic Role of SLC9A1 (NHE1) in Colon Adenocarcinoma. Genel Tıp Derg. 2026;36:1–8.
MLA
Adalı, Yasemin, vd. “Exploring the Prognostic Role of SLC9A1 (NHE1) in Colon Adenocarcinoma”. Genel Tıp Dergisi, c. 36, sy 2026, Mart 2026, ss. 1-8, doi:10.54005/geneltip.1758107.
Vancouver
1.Yasemin Adalı, Berrin Ozdil, Aylin Koseler. Exploring the Prognostic Role of SLC9A1 (NHE1) in Colon Adenocarcinoma. Genel Tıp Derg. 01 Mart 2026;36(2026):1-8. doi:10.54005/geneltip.1758107